Articles with "jun terminal" as a keyword



Photo from wikipedia

Safety, Pharmacokinetics, and Pharmacodynamics of CC‐90001 (BMS‐986360), a c‐Jun N‐terminal Kinase Inhibitor, in Phase 1 Studies in Healthy Participants

Sign Up to like & get
recommendations!
Published in 2022 at "Clinical Pharmacology in Drug Development"

DOI: 10.1002/cpdd.1178

Abstract: CC‐90001 selectively inhibits c‐Jun N‐terminal kinase (JNK), a stress‐activated protein implicated in fibrosis. In 3 phase 1 trials evaluating CC‐90001 pharmacokinetics, pharmacodynamics, and safety, healthy adults (N = 184) received oral CC‐90001 in a single… read more here.

Keywords: safety; pharmacokinetics pharmacodynamics; jun terminal; phase ... See more keywords
Photo from wikipedia

The Role of c-Jun N-Terminal Kinase (JNK) in Retinal Degeneration and Vision Loss.

Sign Up to like & get
recommendations!
Published in 2018 at "Advances in experimental medicine and biology"

DOI: 10.1007/978-3-319-75402-4_43

Abstract: c-Jun N-terminal kinase (JNK), a member of stress-induced mitogen-activated protein (MAP) kinase family, has been shown to modulate a variety of biological processes associated with neurodegenerative pathology of the retina. In particular, various retinal cell… read more here.

Keywords: jnk; jun terminal; kinase jnk; terminal kinase ... See more keywords
Photo from wikipedia

Unraveling the Design and Discovery of c-Jun N-Terminal Kinase Inhibitors and Their Therapeutic Potential in Human Diseases.

Sign Up to like & get
recommendations!
Published in 2022 at "Journal of medicinal chemistry"

DOI: 10.1021/acs.jmedchem.1c01947

Abstract: c-Jun N-terminal kinases (JNKs), members of the mitogen-activated protein kinase (MAPK) family, are encoded by three genes: jnk1, jnk2, and jnk3. JNKs are involved in the pathogenesis and development of many diseases, such as neurodegenerative… read more here.

Keywords: design discovery; kinase; jun terminal; unraveling design ... See more keywords
Photo by diana_pole from unsplash

Tri- and Tetrasubstituted Pyridinylimidazoles as Covalent Inhibitors of c-Jun N-Terminal Kinase 3.

Sign Up to like & get
recommendations!
Published in 2017 at "Journal of medicinal chemistry"

DOI: 10.1021/acs.jmedchem.6b01180

Abstract: The concept of covalent inhibition of c-Jun N-terminal kinase 3 (JNK3) was successfully transferred to our well validated pyridinylimidazole scaffold varying several structural features in order to deduce crucial structure-activity relationships. Joint targeting of the… read more here.

Keywords: pyridinylimidazoles covalent; jun terminal; tri tetrasubstituted; tetrasubstituted pyridinylimidazoles ... See more keywords
Photo from wikipedia

FK866 attenuates acute hepatic failure through c-jun-N-terminal kinase (JNK)-dependent autophagy

Sign Up to like & get
recommendations!
Published in 2017 at "Scientific Reports"

DOI: 10.1038/s41598-017-02318-7

Abstract: FK866 exhibits a protective effect on D-galactosamine (GaIN)/lipopolysaccharide (LPS) and concanavalin A (ConA)-induced acute liver failure (ALF), but the mechanism by which FK866 affords this benefit has not yet been elucidated. Autophagy has a protective… read more here.

Keywords: jnk; jun terminal; terminal kinase; fk866 ... See more keywords
Photo from wikipedia

Non-kinase targeting of oncogenic c-Jun N-terminal kinase (JNK) signaling: the future of clinically viable cancer treatments

Sign Up to like & get
recommendations!
Published in 2022 at "Biochemical Society Transactions"

DOI: 10.1042/bst20220808

Abstract: c-Jun N-terminal Kinases (JNKs) have been identified as key disease drivers in a number of pathophysiological settings and central oncogenic signaling nodes in various cancers. Their roles in driving primary tumor growth, positively regulating cancer… read more here.

Keywords: jnk signaling; jun terminal; jnk; non kinase ... See more keywords
Photo from wikipedia

Silencing NOB1 Can Affect Cell Proliferation and Apoptosis Via the C-Jun N-Terminal Kinase Pathway in Colorectal Cancer

Sign Up to like & get
recommendations!
Published in 2020 at "Journal of Investigative Surgery"

DOI: 10.1080/08941939.2019.1697401

Abstract: Abstract Objectives To investigate the bio-functions and the molecular mechanisms of NIN1/proteasome 26S subunit non-ATPase 8 binding protein 1 homolog (NOB1) in colorectal cancer cells. Methods NOB1 expression was silenced using si-RNA in SW480 and… read more here.

Keywords: apoptosis; kinase; jun terminal; colorectal cancer ... See more keywords
Photo from wikipedia

Gallotannin Improves the Photoaged-Related Proteins by Extracellular Signal-Regulated Kinases/c-Jun N-Terminal Kinases Signaling Pathway in Human Epidermal Keratinocyte Cells.

Sign Up to like & get
recommendations!
Published in 2018 at "Journal of medicinal food"

DOI: 10.1089/jmf.2017.4096

Abstract: Tannins are a type of polyphenols found in several fruits such as grapes and berries, and nuts such as aronias and acorns. Both hydrolyzable tannins and condensed tannins are referred to as tannins. Among the… read more here.

Keywords: kinases jun; jun terminal; extracellular signal; regulated kinases ... See more keywords
Photo from wikipedia

c‐Jun N‐terminal Kinase mediates prostaglandin‐induced sympathoexcitation in rats with chronic heart failure by reducing GAD1 and GABRA1 expression

Sign Up to like & get
recommendations!
Published in 2017 at "Acta Physiologica"

DOI: 10.1111/apha.12758

Abstract: Prostaglandin E2 mediates sympathoexcitation in chronic heart failure (CHF) through EP3 receptors (PTGER3) in the paraventricular nucleus (PVN). The aim of this study was to investigate the role of c‐Jun N‐terminal kinase (JNK) in expressional… read more here.

Keywords: jun terminal; heart failure; terminal kinase; chronic heart ... See more keywords
Photo from wikipedia

CC-90001, a c-Jun N-terminal kinase (JNK) inhibitor, in patients with pulmonary fibrosis: design of a phase 2, randomised, placebo-controlled trial

Sign Up to like & get
recommendations!
Published in 2022 at "BMJ Open Respiratory Research"

DOI: 10.1136/bmjresp-2021-001060

Abstract: Introduction Idiopathic pulmonary fibrosis (IPF) is a progressive and often fatal interstitial lung disease (ILD); other ILDs have a progressive, fibrotic phenotype (PF-ILD). Antifibrotic agents can slow but not stop disease progression in patients with… read more here.

Keywords: week; placebo; jun terminal; pulmonary fibrosis ... See more keywords
Photo by theian20 from unsplash

Involvement of c‐Jun N‐Terminal Kinase in TNF‐&agr;‐Driven Remodeling

Sign Up to like & get
recommendations!
Published in 2017 at "American Journal of Respiratory Cell and Molecular Biology"

DOI: 10.1165/rcmb.2015-0195oc

Abstract: &NA; Lung tissue remodeling in chronic obstructive pulmonary disease (COPD) is characterized by airway wall thickening and/or emphysema. Although the bronchial and alveolar compartments are functionally independent entities, we recently showed comparable alterations in matrix… read more here.

Keywords: tnf; jnk; jun terminal; tnf agr ... See more keywords